title: Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents.
abstract: OBJECTIVE
  Depo-Provera-induced menstrual irregularity is believed to be secondary to relative estrogen deficiency. Weight gain associated with this contraceptive method is believed to be due to Depo-Provera's steroid-like appetite stimulation effect and to an altered tryptophan metabolism. We examined whether vitamin C, an important factor in uterine estrogen binding, and vitamin B(6), a glucocorticoid antagonist and an important coenzyme in the tryptophan-serotonin pathway, might alleviate menstrual irregularities and weight gain associated with Depo-Provera.
  
  
  METHODS
  Fifty-five adolescent girls (age 16 +/- 1 yr, gyn age 4 +/- 1 yr, body mass index 25.2 +/- 0.9) who decided to initiate Depo-Provera (150 mg intramuscularly every 3 months) were randomly assigned to one of four groups (group 1: vitamin B(6) 50 mg plus placebo pill/day; group 2: vitamin C 500 mg plus placebo pill/day; group 3: vitamin B(6) 50 mg plus vitamin C 500 mg/day; group 4 (control): 2 placebo pills/day) for 6 months. Participants were assessed by their care providers every 3 months.
  
  
  METHODS
  Two urban hospital-based adolescent clinics.
  
  
  RESULTS
  Number of days of bleeding during the first interval (first 3 months) as well as during the second interval (months 4-6) among groups 1, 2, and 3 did not differ statistically from days of bleeding in control group. There were no significant body mass index (BMI) changes among groups 1-3 (-0.15 +/- 0.18, 0.34 +/- 0.56, 0.01 +/- 0.31) compared with control (-0.38 +/- 0.38) during the first interval as well as during the second interval (0.68 +/- 0.37, -0.39 +/- 0.21, 0.45 +/- 0.32, compared with 0.28 +/- 0.43). When data from all 55 participants were collapsed, there was no significant change in BMI during the first 6 months of Depo-Provera use. About 48% at 3 months and 44% at 6 months were very or somewhat concerned about menstrual irregularity; 41% at 3 months and 18% at 6 months were very or somewhat concerned about weight changes. More than half (57%) at 3 months and 74% at 6 months reported less tampon/pad use, and 77% at 3 months and 78% at 6 months reported decreased menstrual cramps. Overall, 59% at 3 months and 70% at 6 months were very satisfied with Depo-Provera; 97% at 3 months and 96% at 6 months said that they would recommend Depo-Provera to a friend or a relative.
  
  
  CONCLUSIONS
  This study does not support a role for vitamin C in the prevention of Depo-Provera-induced menstrual irregularities or for vitamin B(6) in the prevention of weight changes associated with Depo-Provera. The unchanged BMI during the first 6 months of Depo-Provera use in the present study suggests that raising awareness and close follow-up may prevent weight gain among adolescent girls using this contraceptive method.
authors.affiliation: Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, RI 02903, USA. Zharel@Lifespan.org
authors.forename: Zeev
authors.initials: Z
authors.lastname: Harel
authors.forename: Frank
authors.initials: F
authors.lastname: Biro
authors.forename: Linda
authors.initials: L
authors.lastname: Kollar
authors.forename: Suzanne
authors.initials: S
authors.lastname: Riggs
authors.forename: Patricia
authors.initials: P
authors.lastname: Flanagan
authors.forename: Rosalind
authors.initials: R
authors.lastname: Vaz
mesh_terms: D000293:Adolescent; D001205:Ascorbic Acid / Q000627:therapeutic use*; D015992:Body Mass Index; D003271:Contraceptive Agents, Female / Q000009:adverse effects* / Q000494:pharmacology; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects* / Q000494:pharmacology; D008599:Menstruation Disturbances / Q000139:chemically induced* / Q000517:prevention & control*; D017060:Patient Satisfaction; D016896:Treatment Outcome; D025101:Vitamin B 6 / Q000627:therapeutic use*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D003271:Contraceptive Agents, Female; D025101:Vitamin B 6; D017258:Medroxyprogesterone Acetate; D001205:Ascorbic Acid